# Leslie's, Inc.: financial statements, quarterly

LESLQ · OTC · CIK 1821806 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Oct 4

Pages: [Overview](/companies/leslq.md) · [Financials](/companies/leslq/financials.md) · [Filings](/companies/leslq/filings.md) · [Insiders](/companies/leslq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/leslq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [432 d](/filings/0001193125-25-323811.md) | [174](/filings/0000950170-25-015474.md) | [189](/filings/0000950170-25-067171.md) | [570](/filings/0000950170-25-105058.md) | [398 d](/filings/0001193125-25-323811.md) | [175](/filings/0001193125-26-056080.md) | [177](/filings/0001193125-26-221811.md) | [500](/filings/0001193125-26-347169.md) | [389 d](/filings/0001193125-25-323811.md) | [147](/filings/0001193125-26-056080.md) | [185](/filings/0001193125-26-221811.md) | [458](/filings/0001193125-26-347169.md) |
| Cost of revenue | $m | [272 d](/filings/0001193125-25-323811.md) | [124](/filings/0000950170-25-015474.md) | [134](/filings/0000950170-25-067171.md) | [341](/filings/0000950170-25-105058.md) | [255 d](/filings/0001193125-25-323811.md) | [128](/filings/0001193125-26-056080.md) | [133](/filings/0001193125-26-221811.md) | [302](/filings/0001193125-26-347169.md) | [239 d](/filings/0001193125-25-323811.md) | [120](/filings/0001193125-26-056080.md) | [131](/filings/0001193125-26-221811.md) | [291](/filings/0001193125-26-347169.md) |
| Gross profit | $m | [160 d](/filings/0001193125-25-323811.md) | [50.4](/filings/0000950170-25-015474.md) | [54.3](/filings/0000950170-25-067171.md) | [229](/filings/0000950170-25-105058.md) | [143 d](/filings/0001193125-25-323811.md) | [47.7](/filings/0001193125-26-056080.md) | [43.9](/filings/0001193125-26-221811.md) | [198](/filings/0001193125-26-347169.md) | [150 d](/filings/0001193125-25-323811.md) | [27.1](/filings/0001193125-26-056080.md) | [53.3](/filings/0001193125-26-221811.md) | [167](/filings/0001193125-26-347169.md) |
| Selling, general and administrative | $m | [122 d](/filings/0001193125-25-323811.md) | [86.9](/filings/0000950170-25-015474.md) | [84.9](/filings/0000950170-25-067171.md) | [131](/filings/0000950170-25-105058.md) | [117 d](/filings/0001193125-25-323811.md) | [87.4](/filings/0001193125-26-056080.md) | [92.3](/filings/0001193125-26-221811.md) | [130](/filings/0001193125-26-347169.md) | [116 d](/filings/0001193125-25-323811.md) | [85.7](/filings/0001193125-26-056080.md) | [92.2](/filings/0001193125-26-221811.md) | [106](/filings/0001193125-26-347169.md) |
| Operating income | $m | [38.5 d](/filings/0001193125-25-323811.md) | [(36.5)](/filings/0000950170-25-015474.md) | [(30.5)](/filings/0000950170-25-067171.md) | [97.7](/filings/0000950170-25-105058.md) | [26.4 d](/filings/0001193125-25-323811.md) | [(39.7)](/filings/0001193125-26-056080.md) | [(48.4)](/filings/0001193125-26-221811.md) | [68.3](/filings/0001193125-26-347169.md) | [(150) d](/filings/0001193125-25-323811.md) | [(68.7)](/filings/0001193125-26-056080.md) | [(37.7)](/filings/0001193125-26-221811.md) | [61.5](/filings/0001193125-26-347169.md) |
| Interest expense | $m | [17.2 d](/filings/0001193125-25-323811.md) | [17.1](/filings/0000950170-25-015474.md) | [18.2](/filings/0000950170-25-067171.md) | [18.2](/filings/0000950170-25-105058.md) | [17.0 d](/filings/0001193125-25-323811.md) | [15.8](/filings/0001193125-26-056080.md) | [15.9](/filings/0001193125-26-221811.md) | [15.8](/filings/0001193125-26-347169.md) | [15.5 d](/filings/0001193125-25-323811.md) | [13.5](/filings/0001193125-26-056080.md) | [14.4](/filings/0001193125-26-221811.md) | [14.1](/filings/0001193125-26-347169.md) |
| Income tax | $m | [4.9 d](/filings/0001193125-25-323811.md) | [(14.0)](/filings/0000950170-25-015474.md) | [(14.1)](/filings/0000950170-25-067171.md) | [18.9](/filings/0000950170-25-105058.md) | [19.3 d](/filings/0001193125-25-323811.md) | [(10.9)](/filings/0001193125-26-056080.md) | [(13.0)](/filings/0001193125-26-221811.md) | [30.8](/filings/0001193125-26-347169.md) | [(2.8) d](/filings/0001193125-25-323811.md) | [0.7](/filings/0001193125-26-056080.md) | [0.4](/filings/0001193125-26-221811.md) | [(0.5)](/filings/0001193125-26-347169.md) |
| Net income | $m | [16.5 d](/filings/0001193125-25-323811.md) | [(39.6)](/filings/0000950170-25-015474.md) | [(34.6)](/filings/0000950170-25-067171.md) | [60.7](/filings/0000950170-25-105058.md) | [(9.9) d](/filings/0001193125-25-323811.md) | [(44.6)](/filings/0001193125-26-056080.md) | [(51.3)](/filings/0001193125-26-221811.md) | [21.7](/filings/0001193125-26-347169.md) | [(163) d](/filings/0001193125-25-323811.md) | [(83.0)](/filings/0001193125-26-056080.md) | [(52.5)](/filings/0001193125-26-221811.md) | [47.8](/filings/0001193125-26-347169.md) |
| Diluted EPS | $ per share | not reported | [(0.21)](/filings/0000950170-25-015474.md) | [(0.19)](/filings/0000950170-25-067171.md) | [0.33](/filings/0000950170-25-105058.md) | not reported | [(4.82)](/filings/0001193125-26-056080.md) | [(5.54)](/filings/0001193125-26-221811.md) | [2.34](/filings/0001193125-26-347169.md) | not reported | [(8.92)](/filings/0001193125-26-056080.md) | [(5.63)](/filings/0001193125-26-221811.md) | [5.01](/filings/0001193125-26-347169.md) |
| Basic EPS | $ per share | not reported | [(0.21)](/filings/0000950170-25-015474.md) | [(0.19)](/filings/0000950170-25-067171.md) | [0.33](/filings/0000950170-25-105058.md) | not reported | [(4.82)](/filings/0001193125-26-056080.md) | [(5.54)](/filings/0001193125-26-221811.md) | [2.34](/filings/0001193125-26-347169.md) | not reported | [(8.92)](/filings/0001193125-26-056080.md) | [(5.63)](/filings/0001193125-26-221811.md) | [5.10](/filings/0001193125-26-347169.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [55.4](/filings/0000950170-24-131476.md) | [8.4](/filings/0000950170-25-015474.md) | [8.4](/filings/0000950170-25-067171.md) | [74.4](/filings/0000950170-25-105058.md) | [109](/filings/0001193125-25-323811.md) | [11.6](/filings/0001193125-26-056080.md) | [17.3](/filings/0001193125-26-221811.md) | [42.7](/filings/0001193125-26-347169.md) | [64.3](/filings/0001193125-26-347169.md) | [3.6](/filings/0001193125-26-056080.md) | [16.9](/filings/0001193125-26-221811.md) | [45.9](/filings/0001193125-26-347169.md) |
| Current assets | $m | [420](/filings/0000950170-24-131476.md) | [392](/filings/0000950170-25-015474.md) | [454](/filings/0000950170-25-067171.md) | [457](/filings/0000950170-25-105058.md) | [422](/filings/0001193125-25-323811.md) | [342](/filings/0001193125-26-056080.md) | [418](/filings/0001193125-26-221811.md) | [385](/filings/0001193125-26-347169.md) | [329](/filings/0001193125-26-347169.md) | [267](/filings/0001193125-26-056080.md) | [340](/filings/0001193125-26-221811.md) | [351](/filings/0001193125-26-347169.md) |
| Total assets | $m | [1,034](/filings/0000950170-24-131476.md) | [999](/filings/0000950170-25-015474.md) | [1,095](/filings/0000950170-25-067171.md) | [1,105](/filings/0000950170-25-105058.md) | [1,050](/filings/0001193125-25-323811.md) | [967](/filings/0001193125-26-056080.md) | [1,043](/filings/0001193125-26-221811.md) | [989](/filings/0001193125-26-347169.md) | [741](/filings/0001193125-26-347169.md) | [649](/filings/0001193125-26-056080.md) | [715](/filings/0001193125-26-221811.md) | [722](/filings/0001193125-26-347169.md) |
| Current liabilities | $m | [226](/filings/0000950170-24-131476.md) | [205](/filings/0000950170-25-015474.md) | [262](/filings/0000950170-25-067171.md) | [286](/filings/0000950170-25-105058.md) | [247](/filings/0001193125-25-323811.md) | [194](/filings/0001193125-26-056080.md) | [268](/filings/0001193125-26-221811.md) | [262](/filings/0001193125-26-347169.md) | [209](/filings/0001193125-26-347169.md) | [188](/filings/0001193125-26-056080.md) | [234](/filings/0001193125-26-221811.md) | [260](/filings/0001193125-26-347169.md) |
| Total liabilities | $m | [1,196](/filings/0000950170-24-131476.md) | [1,197](/filings/0000950170-25-015474.md) | [1,326](/filings/0000950170-25-067171.md) | [1,273](/filings/0000950170-25-105058.md) | [1,227](/filings/0001193125-25-323811.md) | [1,187](/filings/0001193125-26-056080.md) | [1,312](/filings/0001193125-26-221811.md) | [1,236](/filings/0001193125-26-347169.md) | [1,149](/filings/0001193125-26-347169.md) | [1,139](/filings/0001193125-26-056080.md) | [1,257](/filings/0001193125-26-221811.md) | [1,215](/filings/0001193125-26-347169.md) |
| Long-term debt | $m | [773](/filings/0000950170-24-131476.md) | [772](/filings/0000950170-25-015474.md) | [770](/filings/0000950170-25-067171.md) | [769](/filings/0000950170-25-105058.md) | [769](/filings/0001193125-25-323811.md) | [751](/filings/0001193125-26-056080.md) | [751](/filings/0001193125-26-221811.md) | [752](/filings/0001193125-26-347169.md) | [752](/filings/0001193125-26-347169.md) | [752](/filings/0001193125-26-056080.md) | [753](/filings/0001193125-26-221811.md) | [753](/filings/0001193125-26-347169.md) |
| Current portion of debt | $m | [8.1](/filings/0000950170-24-131476.md) | [8.1](/filings/0000950170-25-015474.md) | [8.1](/filings/0000950170-25-067171.md) | [8.1](/filings/0000950170-25-105058.md) | [8.1](/filings/0001193125-25-323811.md) | [0.0](/filings/0000950170-25-015474.md) | [0.0](/filings/0000950170-25-067171.md) | [0.0](/filings/0000950170-25-105058.md) | [0.0](/filings/0001193125-25-323811.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [(161)](/filings/0001193125-25-323811.md) | [(199)](/filings/0000950170-25-067171.md) | [(231)](/filings/0000950170-25-105058.md) | [(168)](/filings/0000950170-25-105058.md) | [(177)](/filings/0001193125-26-347169.md) | [(220)](/filings/0001193125-26-221811.md) | [(269)](/filings/0001193125-26-347169.md) | [(246)](/filings/0001193125-26-347169.md) | [(408)](/filings/0001193125-26-347169.md) | [(490)](/filings/0001193125-26-221811.md) | [(541)](/filings/0001193125-26-347169.md) | [(493)](/filings/0001193125-26-347169.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [81.3 d](/filings/0001193125-25-323811.md) | [(71.9)](/filings/0000950170-25-015474.md) | [(43.2) d](/filings/0000950170-25-067171.md) | [175 d](/filings/0000950170-25-105058.md) | [47.1 d](/filings/0001193125-25-323811.md) | [(105)](/filings/0001193125-26-056080.md) | [(49.2) d](/filings/0001193125-26-221811.md) | [115 d](/filings/0001193125-26-347169.md) | [48.2 d](/filings/0001193125-25-323811.md) | [(81.1)](/filings/0001193125-26-056080.md) | [(55.4) d](/filings/0001193125-26-221811.md) | [99.0 d](/filings/0001193125-26-347169.md) |
| Capital expenditure | $m | [11.8 d](/filings/0001193125-25-323811.md) | [10.7](/filings/0000950170-25-015474.md) | [13.3 d](/filings/0000950170-25-067171.md) | [10.3 d](/filings/0000950170-25-105058.md) | [12.9 d](/filings/0001193125-25-323811.md) | [4.7](/filings/0001193125-26-056080.md) | [6.5 d](/filings/0001193125-26-221811.md) | [7.9 d](/filings/0001193125-26-347169.md) | [6.4 d](/filings/0001193125-25-323811.md) | [4.3](/filings/0001193125-26-056080.md) | [5.2 d](/filings/0001193125-26-221811.md) | [1.0 d](/filings/0001193125-26-347169.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-131476.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [184](/filings/0000950170-24-009961.md) | [184](/filings/0000950170-24-056120.md) | [185](/filings/0000950170-24-093092.md) | [184](/filings/0000950170-25-015474.md) | [185](/filings/0000950170-25-067171.md) | [185](/filings/0000950170-25-105058.md) | [9.3](/filings/0001193125-26-056080.md) | [9.3](/filings/0001193125-26-221811.md) | [9.3](/filings/0001193125-26-347169.md) | [9.3](/filings/0001193125-26-056080.md) | [9.3](/filings/0001193125-26-221811.md) | [9.5](/filings/0001193125-26-347169.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,365,475 at 2026-08-03, from the cover of the [10-Q filed 2026-08-12](/filings/0001193125-26-347169.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.